The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-throughput drug screening (HTDS) of patient-derived tumor organoids (PTDO) from advanced gastrointestinal malignancies: Response and identification of novel therapeutic options.
 
Uqba Khan
Honoraria - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
Other Relationship - 2nd.MD
 
Ilkay Us
No Relationships to Disclose
 
Jenna Moyer
No Relationships to Disclose
 
Pashtoon Murtaza Kasi
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Bayer; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Allyson J. Ocean
No Relationships to Disclose
 
Enrique Podaza
No Relationships to Disclose
 
Sandipto Sarkar
No Relationships to Disclose
 
Oleksandr Savenkov
No Relationships to Disclose
 
M. Laura Martin
No Relationships to Disclose
 
Manish A. Shah
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Oncolys BioPharma (Inst)